PSP Research »

Tango Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $301k 14k 20.92

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Tango Therapeutics

Farallon Capital Management
Boxer Capital Management
Adage Capital Partners GP
TCG Crossover Management
BlackRock
Siren
Woodline Partners
Nextech Invest
Vanguard Group
Trv Gp Iv
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Deerfield Management Company
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics